Follow
Martin Brandl
Martin Brandl
Verified email at sdu.dk - Homepage
Title
Cited by
Cited by
Year
Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics
N Berger, A Sachse, J Bender, R Schubert, M Brandl
International journal of pharmaceutics 223 (1-2), 55-68, 2001
3432001
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ...
European Journal of Pharmaceutical Sciences 137, 104967, 2019
2872019
Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion
GE Flaten, AB Dhanikula, K Luthman, M Brandl
European journal of pharmaceutical sciences 27 (1), 80-90, 2006
2232006
Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”
ST Buckley, KJ Frank, G Fricker, M Brandl
European journal of pharmaceutical sciences 50 (1), 8-16, 2013
2102013
Preparation of liposomes
J Lasch, V Weissig, M Brandl
Liposomes: a practical approach 2, 24-25, 2003
2042003
Liposomes as drug carriers: a technological approach
M Brandl
Elsevier 7, 59-85, 2001
2012001
Drug permeability profiling using cell-free permeation tools: Overview and applications
P Berben, A Bauer-Brandl, M Brandl, B Faller, GE Flaten, AC Jacobsen, ...
European Journal of Pharmaceutical Sciences 119, 219-233, 2018
1892018
Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement
KJ Frank, KM Rosenblatt, U Westedt, P Hölig, J Rosenberg, M Mägerlein, ...
International journal of pharmaceutics 437 (1-2), 288-293, 2012
1592012
In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives
ST Buckley, SM Fischer, G Fricker, M Brandl
European journal of pharmaceutical sciences 45 (3), 235-250, 2012
1542012
Liposome preparation by a new high pressure homogenizer Gaulin Micron Lab 40
M Brandl, D Bachmann, M Drechsler, KH Bauer
Drug Development and Industrial Pharmacy 16 (14), 2167-2191, 1990
1511990
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies
S Martins, I Tho, I Reimold, G Fricker, E Souto, D Ferreira, M Brandl
International journal of pharmaceutics 439 (1-2), 49-62, 2012
1482012
5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties
N Kaiser, A Kimpfler, U Massing, AM Burger, HH Fiebig, M Brandl, ...
International journal of pharmaceutics 256 (1-2), 123-131, 2003
1402003
Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media
I Tho, B Liepold, J Rosenberg, M Maegerlein, M Brandl, G Fricker
European Journal of Pharmaceutical Sciences 40 (1), 25-32, 2010
1362010
Liposome size analysis by dynamic/static light scattering upon size exclusion-/field flow-fractionation
S Hupfeld, AM Holsæter, M Skar, CB Frantzen, M Brandl
Journal of nanoscience and nanotechnology 6 (9-10), 3025-3031, 2006
1322006
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels
R Moog, A Burger, M Brandl, J Schüler, R Schubert, C Unger, H Fiebig, ...
Cancer chemotherapy and pharmacology 49, 356-366, 2002
1192002
What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?
KJ Frank, U Westedt, KM Rosenblatt, P Hölig, J Rosenberg, M Mägerlein, ...
Journal of pharmaceutical sciences 103 (6), 1779-1786, 2014
1092014
In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation
J Kanzer, S Hupfeld, T Vasskog, I Tho, P Hölig, M Mägerlein, G Fricker, ...
Journal of pharmaceutical and biomedical analysis 53 (3), 359-365, 2010
912010
Oral bioavailability enhancement through supersaturation: an update and meta-analysis
SYK Fong, A Bauer-Brandl, M Brandl
Expert opinion on drug delivery 14 (3), 403-426, 2017
902017
Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery
TJ Evjen, EA Nilssen, S Rögnvaldsson, M Brandl, SL Fossheim
European Journal of Pharmaceutics and Biopharmaceutics 75 (3), 327-333, 2010
902010
Drug permeability across a phospholipid vesicle-based barrier: 2. Characterization of barrier structure, storage stability and stability towards pH changes
GE Flaten, H Bunjes, K Luthman, M Brandl
European journal of pharmaceutical sciences 28 (4), 336-343, 2006
872006
The system can't perform the operation now. Try again later.
Articles 1–20